Mining Cholesterol Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mining Cholesterol

EVR 344.67

0.0%

Dec 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: E. Charters	5/23/2006 8:59:12 PM
	Read Replies (1) of 356

What is all this stuff about L-Arginine and the new study? Anybody got the scoop? Is it dangerous for cardiac patients? nutraingredients.com There are a number of caveats. Size of study group, standard error expected should be looked at. L-Arginine is a powerful vascular dilator, or at least promotes NO which is the major vascular dilator in opposition to angiotensin which is the major promoter of peripheral vascular clamping. It may be that with patients with recent heart attack history or heart failure that vascular dilation is too drastic a measure for their systems. The other thing to look at is the actual composition of the L-Arginine. A while back there was a tryptophan scare and it turned out that bad manufacturing practices led to an introduced toxin. The double-blind, randomised study followed 153 patients with an average age of 60 for six months. One group was given a placebo, while the others were given 9g daily doses of L-arginine. Old sick guys should not take certain quantities of L-Arginine in the absence of all other drugs one surmises. If indeed they were on any other drugs. Interactions anyone? EC<:-}

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next